nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA9—breast cancer	0.298	0.776	CbGaD
Topiramate—CYP3A4—breast cancer	0.0857	0.224	CbGaD
Topiramate—CYP2C19—Lapatinib—breast cancer	0.0218	0.115	CbGbCtD
Topiramate—CYP3A4—Exemestane—breast cancer	0.0208	0.11	CbGbCtD
Topiramate—CYP3A4—Letrozole—breast cancer	0.0177	0.0935	CbGbCtD
Topiramate—CYP3A4—Anastrozole—breast cancer	0.0158	0.0833	CbGbCtD
Topiramate—CYP3A4—Toremifene—breast cancer	0.0144	0.0762	CbGbCtD
Topiramate—CYP3A4—Fulvestrant—breast cancer	0.0134	0.0708	CbGbCtD
Topiramate—CYP3A4—Thiotepa—breast cancer	0.0119	0.0631	CbGbCtD
Topiramate—CYP3A4—Ixabepilone—breast cancer	0.0109	0.0577	CbGbCtD
Topiramate—CYP2C19—Tamoxifen—breast cancer	0.0109	0.0576	CbGbCtD
Topiramate—CYP3A4—Lapatinib—breast cancer	0.0105	0.0556	CbGbCtD
Topiramate—CYP3A4—Raloxifene—breast cancer	0.00797	0.0421	CbGbCtD
Topiramate—CYP3A4—Vinorelbine—breast cancer	0.00583	0.0308	CbGbCtD
Topiramate—CYP3A4—Tamoxifen—breast cancer	0.00526	0.0278	CbGbCtD
Topiramate—CYP3A4—Mitoxantrone—breast cancer	0.00513	0.0271	CbGbCtD
Topiramate—CYP3A4—Paclitaxel—breast cancer	0.0041	0.0217	CbGbCtD
Topiramate—CYP3A4—Irinotecan—breast cancer	0.00404	0.0214	CbGbCtD
Topiramate—CYP3A4—Vinblastine—breast cancer	0.00359	0.019	CbGbCtD
Topiramate—CYP3A4—Docetaxel—breast cancer	0.00296	0.0157	CbGbCtD
Topiramate—CYP3A4—Doxorubicin—breast cancer	0.00221	0.0117	CbGbCtD
Topiramate—GRIK5—pituitary gland—breast cancer	0.00209	0.0508	CbGeAlD
Topiramate—GRIK3—pituitary gland—breast cancer	0.00209	0.0508	CbGeAlD
Topiramate—GRIK3—female reproductive system—breast cancer	0.00191	0.0465	CbGeAlD
Topiramate—GRIK5—adrenal gland—breast cancer	0.00187	0.0454	CbGeAlD
Topiramate—GRIK3—adrenal gland—breast cancer	0.00187	0.0454	CbGeAlD
Topiramate—GRIK1—female gonad—breast cancer	0.00165	0.0402	CbGeAlD
Topiramate—GRIA3—adrenal gland—breast cancer	0.00165	0.0401	CbGeAlD
Topiramate—GRIK1—endocrine gland—breast cancer	0.00154	0.0374	CbGeAlD
Topiramate—CA5A—female reproductive system—breast cancer	0.0014	0.0341	CbGeAlD
Topiramate—CA5B—mammary gland—breast cancer	0.00131	0.0319	CbGeAlD
Topiramate—CA5A—endocrine gland—breast cancer	0.00119	0.0288	CbGeAlD
Topiramate—GRIA2—embryo—breast cancer	0.00118	0.0288	CbGeAlD
Topiramate—GRIK5—lymph node—breast cancer	0.00112	0.0272	CbGeAlD
Topiramate—GRIK3—lymph node—breast cancer	0.00112	0.0272	CbGeAlD
Topiramate—GRIA1—adipose tissue—breast cancer	0.000982	0.0239	CbGeAlD
Topiramate—CA9—female reproductive system—breast cancer	0.000818	0.0199	CbGeAlD
Topiramate—GRIA1—endocrine gland—breast cancer	0.000764	0.0186	CbGeAlD
Topiramate—CA4—nipple—breast cancer	0.000749	0.0182	CbGeAlD
Topiramate—CA9—endocrine gland—breast cancer	0.000693	0.0168	CbGeAlD
Topiramate—CA2—nipple—breast cancer	0.000621	0.0151	CbGeAlD
Topiramate—GRIA2—endocrine gland—breast cancer	0.000607	0.0148	CbGeAlD
Topiramate—CA12—female reproductive system—breast cancer	0.000605	0.0147	CbGeAlD
Topiramate—CA5B—adipose tissue—breast cancer	0.000591	0.0144	CbGeAlD
Topiramate—GABRG2—pituitary gland—breast cancer	0.000557	0.0136	CbGeAlD
Topiramate—GRIK2—endocrine gland—breast cancer	0.000548	0.0133	CbGeAlD
Topiramate—CA5B—female reproductive system—breast cancer	0.000543	0.0132	CbGeAlD
Topiramate—CA5B—adrenal gland—breast cancer	0.00053	0.0129	CbGeAlD
Topiramate—CA1—adipose tissue—breast cancer	0.000522	0.0127	CbGeAlD
Topiramate—CA2—embryo—breast cancer	0.000513	0.0125	CbGeAlD
Topiramate—CA12—endocrine gland—breast cancer	0.000512	0.0125	CbGeAlD
Topiramate—CA1—female reproductive system—breast cancer	0.00048	0.0117	CbGeAlD
Topiramate—CA5B—endocrine gland—breast cancer	0.00046	0.0112	CbGeAlD
Topiramate—CA1—bone marrow—breast cancer	0.000453	0.011	CbGeAlD
Topiramate—CA2—epithelium—breast cancer	0.000418	0.0102	CbGeAlD
Topiramate—CA4—pituitary gland—breast cancer	0.000409	0.00996	CbGeAlD
Topiramate—CA4—adipose tissue—breast cancer	0.000408	0.00992	CbGeAlD
Topiramate—CA1—endocrine gland—breast cancer	0.000406	0.00987	CbGeAlD
Topiramate—CA2—skin of body—breast cancer	0.000398	0.00968	CbGeAlD
Topiramate—CA4—female reproductive system—breast cancer	0.000375	0.00912	CbGeAlD
Topiramate—CA4—adrenal gland—breast cancer	0.000366	0.0089	CbGeAlD
Topiramate—CA4—bone marrow—breast cancer	0.000354	0.00861	CbGeAlD
Topiramate—CA4—female gonad—breast cancer	0.000341	0.00829	CbGeAlD
Topiramate—CA2—pituitary gland—breast cancer	0.00034	0.00826	CbGeAlD
Topiramate—CA2—adipose tissue—breast cancer	0.000338	0.00822	CbGeAlD
Topiramate—CA5B—lymph node—breast cancer	0.000318	0.00773	CbGeAlD
Topiramate—CA4—endocrine gland—breast cancer	0.000317	0.00771	CbGeAlD
Topiramate—CA2—female reproductive system—breast cancer	0.000311	0.00756	CbGeAlD
Topiramate—CA2—adrenal gland—breast cancer	0.000303	0.00738	CbGeAlD
Topiramate—CA2—bone marrow—breast cancer	0.000293	0.00714	CbGeAlD
Topiramate—CYP2C19—endocrine gland—breast cancer	0.000287	0.00698	CbGeAlD
Topiramate—CA2—female gonad—breast cancer	0.000283	0.00688	CbGeAlD
Topiramate—CA1—lymph node—breast cancer	0.000281	0.00682	CbGeAlD
Topiramate—CA2—endocrine gland—breast cancer	0.000263	0.0064	CbGeAlD
Topiramate—CA4—lymph node—breast cancer	0.000219	0.00533	CbGeAlD
Topiramate—CYP3A4—female reproductive system—breast cancer	0.000201	0.00488	CbGeAlD
Topiramate—CA2—lymph node—breast cancer	0.000182	0.00442	CbGeAlD
Topiramate—CYP3A4—endocrine gland—breast cancer	0.00017	0.00413	CbGeAlD
Topiramate—Gastrointestinal disorder—Docetaxel—breast cancer	2.33e-05	8.56e-05	CcSEcCtD
Topiramate—Connective tissue disorder—Doxorubicin—breast cancer	2.33e-05	8.56e-05	CcSEcCtD
Topiramate—Dyspnoea—Capecitabine—breast cancer	2.33e-05	8.56e-05	CcSEcCtD
Topiramate—Fatigue—Docetaxel—breast cancer	2.32e-05	8.55e-05	CcSEcCtD
Topiramate—Angiopathy—Epirubicin—breast cancer	2.32e-05	8.54e-05	CcSEcCtD
Topiramate—Urethral disorder—Doxorubicin—breast cancer	2.32e-05	8.54e-05	CcSEcCtD
Topiramate—Nausea—Mitoxantrone—breast cancer	2.32e-05	8.52e-05	CcSEcCtD
Topiramate—Nausea—Irinotecan—breast cancer	2.32e-05	8.52e-05	CcSEcCtD
Topiramate—Immune system disorder—Epirubicin—breast cancer	2.31e-05	8.5e-05	CcSEcCtD
Topiramate—Mediastinal disorder—Epirubicin—breast cancer	2.31e-05	8.48e-05	CcSEcCtD
Topiramate—Pain—Docetaxel—breast cancer	2.3e-05	8.48e-05	CcSEcCtD
Topiramate—Constipation—Docetaxel—breast cancer	2.3e-05	8.48e-05	CcSEcCtD
Topiramate—Back pain—Methotrexate—breast cancer	2.3e-05	8.47e-05	CcSEcCtD
Topiramate—Dyspepsia—Capecitabine—breast cancer	2.3e-05	8.45e-05	CcSEcCtD
Topiramate—Chills—Epirubicin—breast cancer	2.3e-05	8.44e-05	CcSEcCtD
Topiramate—Visual impairment—Doxorubicin—breast cancer	2.28e-05	8.39e-05	CcSEcCtD
Topiramate—Asthenia—Paclitaxel—breast cancer	2.28e-05	8.39e-05	CcSEcCtD
Topiramate—Decreased appetite—Capecitabine—breast cancer	2.27e-05	8.34e-05	CcSEcCtD
Topiramate—Alopecia—Epirubicin—breast cancer	2.26e-05	8.32e-05	CcSEcCtD
Topiramate—Nausea—Gemcitabine—breast cancer	2.26e-05	8.3e-05	CcSEcCtD
Topiramate—Gastrointestinal disorder—Capecitabine—breast cancer	2.25e-05	8.29e-05	CcSEcCtD
Topiramate—Fatigue—Capecitabine—breast cancer	2.25e-05	8.27e-05	CcSEcCtD
Topiramate—Pruritus—Paclitaxel—breast cancer	2.25e-05	8.27e-05	CcSEcCtD
Topiramate—Vision blurred—Methotrexate—breast cancer	2.24e-05	8.25e-05	CcSEcCtD
Topiramate—Mental disorder—Epirubicin—breast cancer	2.24e-05	8.24e-05	CcSEcCtD
Topiramate—Erythema multiforme—Doxorubicin—breast cancer	2.24e-05	8.23e-05	CcSEcCtD
Topiramate—Constipation—Capecitabine—breast cancer	2.23e-05	8.21e-05	CcSEcCtD
Topiramate—Pain—Capecitabine—breast cancer	2.23e-05	8.21e-05	CcSEcCtD
Topiramate—Malnutrition—Epirubicin—breast cancer	2.23e-05	8.19e-05	CcSEcCtD
Topiramate—Erythema—Epirubicin—breast cancer	2.23e-05	8.19e-05	CcSEcCtD
Topiramate—Feeling abnormal—Docetaxel—breast cancer	2.22e-05	8.17e-05	CcSEcCtD
Topiramate—Nausea—Fluorouracil—breast cancer	2.22e-05	8.16e-05	CcSEcCtD
Topiramate—Eye disorder—Doxorubicin—breast cancer	2.21e-05	8.14e-05	CcSEcCtD
Topiramate—Ill-defined disorder—Methotrexate—breast cancer	2.21e-05	8.12e-05	CcSEcCtD
Topiramate—Tinnitus—Doxorubicin—breast cancer	2.21e-05	8.12e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Docetaxel—breast cancer	2.2e-05	8.11e-05	CcSEcCtD
Topiramate—Anaemia—Methotrexate—breast cancer	2.2e-05	8.09e-05	CcSEcCtD
Topiramate—Flushing—Doxorubicin—breast cancer	2.2e-05	8.08e-05	CcSEcCtD
Topiramate—Cardiac disorder—Doxorubicin—breast cancer	2.2e-05	8.08e-05	CcSEcCtD
Topiramate—Flatulence—Epirubicin—breast cancer	2.19e-05	8.07e-05	CcSEcCtD
Topiramate—Tension—Epirubicin—breast cancer	2.19e-05	8.04e-05	CcSEcCtD
Topiramate—Dysgeusia—Epirubicin—breast cancer	2.18e-05	8.02e-05	CcSEcCtD
Topiramate—Diarrhoea—Paclitaxel—breast cancer	2.17e-05	8e-05	CcSEcCtD
Topiramate—Nervousness—Epirubicin—breast cancer	2.16e-05	7.96e-05	CcSEcCtD
Topiramate—Back pain—Epirubicin—breast cancer	2.15e-05	7.92e-05	CcSEcCtD
Topiramate—Feeling abnormal—Capecitabine—breast cancer	2.15e-05	7.91e-05	CcSEcCtD
Topiramate—Angiopathy—Doxorubicin—breast cancer	2.15e-05	7.9e-05	CcSEcCtD
Topiramate—Malaise—Methotrexate—breast cancer	2.15e-05	7.89e-05	CcSEcCtD
Topiramate—Muscle spasms—Epirubicin—breast cancer	2.14e-05	7.88e-05	CcSEcCtD
Topiramate—Immune system disorder—Doxorubicin—breast cancer	2.14e-05	7.87e-05	CcSEcCtD
Topiramate—Vertigo—Methotrexate—breast cancer	2.14e-05	7.87e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Capecitabine—breast cancer	2.13e-05	7.85e-05	CcSEcCtD
Topiramate—Mediastinal disorder—Doxorubicin—breast cancer	2.13e-05	7.85e-05	CcSEcCtD
Topiramate—Abdominal pain—Docetaxel—breast cancer	2.13e-05	7.84e-05	CcSEcCtD
Topiramate—Body temperature increased—Docetaxel—breast cancer	2.13e-05	7.84e-05	CcSEcCtD
Topiramate—Leukopenia—Methotrexate—breast cancer	2.13e-05	7.84e-05	CcSEcCtD
Topiramate—Chills—Doxorubicin—breast cancer	2.12e-05	7.81e-05	CcSEcCtD
Topiramate—Dizziness—Paclitaxel—breast cancer	2.1e-05	7.73e-05	CcSEcCtD
Topiramate—Vision blurred—Epirubicin—breast cancer	2.1e-05	7.72e-05	CcSEcCtD
Topiramate—Alopecia—Doxorubicin—breast cancer	2.09e-05	7.69e-05	CcSEcCtD
Topiramate—Cough—Methotrexate—breast cancer	2.08e-05	7.64e-05	CcSEcCtD
Topiramate—Mental disorder—Doxorubicin—breast cancer	2.07e-05	7.63e-05	CcSEcCtD
Topiramate—Urticaria—Capecitabine—breast cancer	2.07e-05	7.62e-05	CcSEcCtD
Topiramate—Ill-defined disorder—Epirubicin—breast cancer	2.07e-05	7.6e-05	CcSEcCtD
Topiramate—Abdominal pain—Capecitabine—breast cancer	2.06e-05	7.59e-05	CcSEcCtD
Topiramate—Body temperature increased—Capecitabine—breast cancer	2.06e-05	7.59e-05	CcSEcCtD
Topiramate—Convulsion—Methotrexate—breast cancer	2.06e-05	7.58e-05	CcSEcCtD
Topiramate—Malnutrition—Doxorubicin—breast cancer	2.06e-05	7.58e-05	CcSEcCtD
Topiramate—Erythema—Doxorubicin—breast cancer	2.06e-05	7.58e-05	CcSEcCtD
Topiramate—Anaemia—Epirubicin—breast cancer	2.06e-05	7.57e-05	CcSEcCtD
Topiramate—Agitation—Epirubicin—breast cancer	2.05e-05	7.53e-05	CcSEcCtD
Topiramate—Flatulence—Doxorubicin—breast cancer	2.03e-05	7.47e-05	CcSEcCtD
Topiramate—Arthralgia—Methotrexate—breast cancer	2.03e-05	7.45e-05	CcSEcCtD
Topiramate—Chest pain—Methotrexate—breast cancer	2.03e-05	7.45e-05	CcSEcCtD
Topiramate—Myalgia—Methotrexate—breast cancer	2.03e-05	7.45e-05	CcSEcCtD
Topiramate—Tension—Doxorubicin—breast cancer	2.02e-05	7.44e-05	CcSEcCtD
Topiramate—Vomiting—Paclitaxel—breast cancer	2.02e-05	7.44e-05	CcSEcCtD
Topiramate—Dysgeusia—Doxorubicin—breast cancer	2.02e-05	7.42e-05	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.01e-05	7.4e-05	CcSEcCtD
Topiramate—Malaise—Epirubicin—breast cancer	2.01e-05	7.39e-05	CcSEcCtD
Topiramate—Rash—Paclitaxel—breast cancer	2e-05	7.37e-05	CcSEcCtD
Topiramate—Dermatitis—Paclitaxel—breast cancer	2e-05	7.37e-05	CcSEcCtD
Topiramate—Discomfort—Methotrexate—breast cancer	2e-05	7.36e-05	CcSEcCtD
Topiramate—Nervousness—Doxorubicin—breast cancer	2e-05	7.36e-05	CcSEcCtD
Topiramate—Vertigo—Epirubicin—breast cancer	2e-05	7.36e-05	CcSEcCtD
Topiramate—Syncope—Epirubicin—breast cancer	2e-05	7.35e-05	CcSEcCtD
Topiramate—Leukopenia—Epirubicin—breast cancer	1.99e-05	7.33e-05	CcSEcCtD
Topiramate—Back pain—Doxorubicin—breast cancer	1.99e-05	7.33e-05	CcSEcCtD
Topiramate—Headache—Paclitaxel—breast cancer	1.99e-05	7.33e-05	CcSEcCtD
Topiramate—Hypersensitivity—Docetaxel—breast cancer	1.99e-05	7.3e-05	CcSEcCtD
Topiramate—Muscle spasms—Doxorubicin—breast cancer	1.98e-05	7.29e-05	CcSEcCtD
Topiramate—Palpitations—Epirubicin—breast cancer	1.97e-05	7.24e-05	CcSEcCtD
Topiramate—Confusional state—Methotrexate—breast cancer	1.96e-05	7.2e-05	CcSEcCtD
Topiramate—Loss of consciousness—Epirubicin—breast cancer	1.96e-05	7.2e-05	CcSEcCtD
Topiramate—Cough—Epirubicin—breast cancer	1.94e-05	7.15e-05	CcSEcCtD
Topiramate—Vision blurred—Doxorubicin—breast cancer	1.94e-05	7.14e-05	CcSEcCtD
Topiramate—Asthenia—Docetaxel—breast cancer	1.93e-05	7.11e-05	CcSEcCtD
Topiramate—Convulsion—Epirubicin—breast cancer	1.93e-05	7.1e-05	CcSEcCtD
Topiramate—Infection—Methotrexate—breast cancer	1.93e-05	7.1e-05	CcSEcCtD
Topiramate—Hypertension—Epirubicin—breast cancer	1.92e-05	7.07e-05	CcSEcCtD
Topiramate—Hypersensitivity—Capecitabine—breast cancer	1.92e-05	7.07e-05	CcSEcCtD
Topiramate—Ill-defined disorder—Doxorubicin—breast cancer	1.91e-05	7.03e-05	CcSEcCtD
Topiramate—Pruritus—Docetaxel—breast cancer	1.91e-05	7.01e-05	CcSEcCtD
Topiramate—Nervous system disorder—Methotrexate—breast cancer	1.9e-05	7.01e-05	CcSEcCtD
Topiramate—Anaemia—Doxorubicin—breast cancer	1.9e-05	7.01e-05	CcSEcCtD
Topiramate—Thrombocytopenia—Methotrexate—breast cancer	1.9e-05	7e-05	CcSEcCtD
Topiramate—Chest pain—Epirubicin—breast cancer	1.9e-05	6.97e-05	CcSEcCtD
Topiramate—Arthralgia—Epirubicin—breast cancer	1.9e-05	6.97e-05	CcSEcCtD
Topiramate—Myalgia—Epirubicin—breast cancer	1.9e-05	6.97e-05	CcSEcCtD
Topiramate—Agitation—Doxorubicin—breast cancer	1.89e-05	6.97e-05	CcSEcCtD
Topiramate—Anxiety—Epirubicin—breast cancer	1.89e-05	6.95e-05	CcSEcCtD
Topiramate—Nausea—Paclitaxel—breast cancer	1.89e-05	6.95e-05	CcSEcCtD
Topiramate—Skin disorder—Methotrexate—breast cancer	1.89e-05	6.94e-05	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.88e-05	6.93e-05	CcSEcCtD
Topiramate—Hyperhidrosis—Methotrexate—breast cancer	1.88e-05	6.91e-05	CcSEcCtD
Topiramate—Discomfort—Epirubicin—breast cancer	1.87e-05	6.89e-05	CcSEcCtD
Topiramate—Asthenia—Capecitabine—breast cancer	1.87e-05	6.89e-05	CcSEcCtD
Topiramate—Malaise—Doxorubicin—breast cancer	1.86e-05	6.84e-05	CcSEcCtD
Topiramate—Dry mouth—Epirubicin—breast cancer	1.85e-05	6.82e-05	CcSEcCtD
Topiramate—Vertigo—Doxorubicin—breast cancer	1.85e-05	6.81e-05	CcSEcCtD
Topiramate—Anorexia—Methotrexate—breast cancer	1.85e-05	6.81e-05	CcSEcCtD
Topiramate—Syncope—Doxorubicin—breast cancer	1.85e-05	6.8e-05	CcSEcCtD
Topiramate—Pruritus—Capecitabine—breast cancer	1.85e-05	6.79e-05	CcSEcCtD
Topiramate—Leukopenia—Doxorubicin—breast cancer	1.84e-05	6.79e-05	CcSEcCtD
Topiramate—Diarrhoea—Docetaxel—breast cancer	1.84e-05	6.78e-05	CcSEcCtD
Topiramate—Confusional state—Epirubicin—breast cancer	1.83e-05	6.74e-05	CcSEcCtD
Topiramate—Palpitations—Doxorubicin—breast cancer	1.82e-05	6.7e-05	CcSEcCtD
Topiramate—Oedema—Epirubicin—breast cancer	1.82e-05	6.69e-05	CcSEcCtD
Topiramate—Hypotension—Methotrexate—breast cancer	1.81e-05	6.68e-05	CcSEcCtD
Topiramate—Loss of consciousness—Doxorubicin—breast cancer	1.81e-05	6.66e-05	CcSEcCtD
Topiramate—Infection—Epirubicin—breast cancer	1.81e-05	6.64e-05	CcSEcCtD
Topiramate—Cough—Doxorubicin—breast cancer	1.8e-05	6.61e-05	CcSEcCtD
Topiramate—Shock—Epirubicin—breast cancer	1.79e-05	6.58e-05	CcSEcCtD
Topiramate—Convulsion—Doxorubicin—breast cancer	1.79e-05	6.57e-05	CcSEcCtD
Topiramate—Diarrhoea—Capecitabine—breast cancer	1.78e-05	6.57e-05	CcSEcCtD
Topiramate—Nervous system disorder—Epirubicin—breast cancer	1.78e-05	6.56e-05	CcSEcCtD
Topiramate—Dizziness—Docetaxel—breast cancer	1.78e-05	6.56e-05	CcSEcCtD
Topiramate—Thrombocytopenia—Epirubicin—breast cancer	1.78e-05	6.55e-05	CcSEcCtD
Topiramate—Hypertension—Doxorubicin—breast cancer	1.78e-05	6.54e-05	CcSEcCtD
Topiramate—Tachycardia—Epirubicin—breast cancer	1.77e-05	6.53e-05	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Methotrexate—breast cancer	1.77e-05	6.51e-05	CcSEcCtD
Topiramate—Skin disorder—Epirubicin—breast cancer	1.77e-05	6.49e-05	CcSEcCtD
Topiramate—Hyperhidrosis—Epirubicin—breast cancer	1.76e-05	6.46e-05	CcSEcCtD
Topiramate—Insomnia—Methotrexate—breast cancer	1.76e-05	6.46e-05	CcSEcCtD
Topiramate—Arthralgia—Doxorubicin—breast cancer	1.75e-05	6.45e-05	CcSEcCtD
Topiramate—Chest pain—Doxorubicin—breast cancer	1.75e-05	6.45e-05	CcSEcCtD
Topiramate—Myalgia—Doxorubicin—breast cancer	1.75e-05	6.45e-05	CcSEcCtD
Topiramate—Anxiety—Doxorubicin—breast cancer	1.75e-05	6.43e-05	CcSEcCtD
Topiramate—Paraesthesia—Methotrexate—breast cancer	1.74e-05	6.42e-05	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.74e-05	6.41e-05	CcSEcCtD
Topiramate—Discomfort—Doxorubicin—breast cancer	1.73e-05	6.38e-05	CcSEcCtD
Topiramate—Anorexia—Epirubicin—breast cancer	1.73e-05	6.37e-05	CcSEcCtD
Topiramate—Dyspnoea—Methotrexate—breast cancer	1.73e-05	6.37e-05	CcSEcCtD
Topiramate—Somnolence—Methotrexate—breast cancer	1.73e-05	6.35e-05	CcSEcCtD
Topiramate—Dizziness—Capecitabine—breast cancer	1.73e-05	6.35e-05	CcSEcCtD
Topiramate—Dry mouth—Doxorubicin—breast cancer	1.72e-05	6.31e-05	CcSEcCtD
Topiramate—Vomiting—Docetaxel—breast cancer	1.71e-05	6.3e-05	CcSEcCtD
Topiramate—Dyspepsia—Methotrexate—breast cancer	1.71e-05	6.29e-05	CcSEcCtD
Topiramate—Rash—Docetaxel—breast cancer	1.7e-05	6.25e-05	CcSEcCtD
Topiramate—Hypotension—Epirubicin—breast cancer	1.7e-05	6.25e-05	CcSEcCtD
Topiramate—Dermatitis—Docetaxel—breast cancer	1.7e-05	6.24e-05	CcSEcCtD
Topiramate—Confusional state—Doxorubicin—breast cancer	1.7e-05	6.24e-05	CcSEcCtD
Topiramate—Decreased appetite—Methotrexate—breast cancer	1.69e-05	6.21e-05	CcSEcCtD
Topiramate—Headache—Docetaxel—breast cancer	1.69e-05	6.21e-05	CcSEcCtD
Topiramate—Oedema—Doxorubicin—breast cancer	1.68e-05	6.19e-05	CcSEcCtD
Topiramate—Gastrointestinal disorder—Methotrexate—breast cancer	1.68e-05	6.17e-05	CcSEcCtD
Topiramate—Fatigue—Methotrexate—breast cancer	1.67e-05	6.16e-05	CcSEcCtD
Topiramate—Infection—Doxorubicin—breast cancer	1.67e-05	6.15e-05	CcSEcCtD
Topiramate—Pain—Methotrexate—breast cancer	1.66e-05	6.11e-05	CcSEcCtD
Topiramate—Vomiting—Capecitabine—breast cancer	1.66e-05	6.1e-05	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Epirubicin—breast cancer	1.66e-05	6.09e-05	CcSEcCtD
Topiramate—Shock—Doxorubicin—breast cancer	1.65e-05	6.09e-05	CcSEcCtD
Topiramate—Nervous system disorder—Doxorubicin—breast cancer	1.65e-05	6.07e-05	CcSEcCtD
Topiramate—Thrombocytopenia—Doxorubicin—breast cancer	1.65e-05	6.06e-05	CcSEcCtD
Topiramate—Rash—Capecitabine—breast cancer	1.64e-05	6.05e-05	CcSEcCtD
Topiramate—Insomnia—Epirubicin—breast cancer	1.64e-05	6.05e-05	CcSEcCtD
Topiramate—Dermatitis—Capecitabine—breast cancer	1.64e-05	6.05e-05	CcSEcCtD
Topiramate—Tachycardia—Doxorubicin—breast cancer	1.64e-05	6.04e-05	CcSEcCtD
Topiramate—Headache—Capecitabine—breast cancer	1.63e-05	6.01e-05	CcSEcCtD
Topiramate—Skin disorder—Doxorubicin—breast cancer	1.63e-05	6.01e-05	CcSEcCtD
Topiramate—Paraesthesia—Epirubicin—breast cancer	1.63e-05	6e-05	CcSEcCtD
Topiramate—Hyperhidrosis—Doxorubicin—breast cancer	1.63e-05	5.98e-05	CcSEcCtD
Topiramate—Dyspnoea—Epirubicin—breast cancer	1.62e-05	5.96e-05	CcSEcCtD
Topiramate—Somnolence—Epirubicin—breast cancer	1.62e-05	5.94e-05	CcSEcCtD
Topiramate—Anorexia—Doxorubicin—breast cancer	1.6e-05	5.9e-05	CcSEcCtD
Topiramate—Nausea—Docetaxel—breast cancer	1.6e-05	5.89e-05	CcSEcCtD
Topiramate—Feeling abnormal—Methotrexate—breast cancer	1.6e-05	5.89e-05	CcSEcCtD
Topiramate—Dyspepsia—Epirubicin—breast cancer	1.6e-05	5.89e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Methotrexate—breast cancer	1.59e-05	5.84e-05	CcSEcCtD
Topiramate—Decreased appetite—Epirubicin—breast cancer	1.58e-05	5.81e-05	CcSEcCtD
Topiramate—Hypotension—Doxorubicin—breast cancer	1.57e-05	5.78e-05	CcSEcCtD
Topiramate—Gastrointestinal disorder—Epirubicin—breast cancer	1.57e-05	5.77e-05	CcSEcCtD
Topiramate—Fatigue—Epirubicin—breast cancer	1.57e-05	5.76e-05	CcSEcCtD
Topiramate—Pain—Epirubicin—breast cancer	1.55e-05	5.72e-05	CcSEcCtD
Topiramate—Constipation—Epirubicin—breast cancer	1.55e-05	5.72e-05	CcSEcCtD
Topiramate—Nausea—Capecitabine—breast cancer	1.55e-05	5.7e-05	CcSEcCtD
Topiramate—Urticaria—Methotrexate—breast cancer	1.54e-05	5.68e-05	CcSEcCtD
Topiramate—Abdominal pain—Methotrexate—breast cancer	1.54e-05	5.65e-05	CcSEcCtD
Topiramate—Body temperature increased—Methotrexate—breast cancer	1.54e-05	5.65e-05	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.53e-05	5.64e-05	CcSEcCtD
Topiramate—Insomnia—Doxorubicin—breast cancer	1.52e-05	5.6e-05	CcSEcCtD
Topiramate—Paraesthesia—Doxorubicin—breast cancer	1.51e-05	5.56e-05	CcSEcCtD
Topiramate—Dyspnoea—Doxorubicin—breast cancer	1.5e-05	5.52e-05	CcSEcCtD
Topiramate—Feeling abnormal—Epirubicin—breast cancer	1.5e-05	5.51e-05	CcSEcCtD
Topiramate—Somnolence—Doxorubicin—breast cancer	1.49e-05	5.5e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Epirubicin—breast cancer	1.49e-05	5.47e-05	CcSEcCtD
Topiramate—Dyspepsia—Doxorubicin—breast cancer	1.48e-05	5.45e-05	CcSEcCtD
Topiramate—Decreased appetite—Doxorubicin—breast cancer	1.46e-05	5.38e-05	CcSEcCtD
Topiramate—Gastrointestinal disorder—Doxorubicin—breast cancer	1.45e-05	5.34e-05	CcSEcCtD
Topiramate—Fatigue—Doxorubicin—breast cancer	1.45e-05	5.33e-05	CcSEcCtD
Topiramate—Urticaria—Epirubicin—breast cancer	1.44e-05	5.31e-05	CcSEcCtD
Topiramate—Pain—Doxorubicin—breast cancer	1.44e-05	5.29e-05	CcSEcCtD
Topiramate—Constipation—Doxorubicin—breast cancer	1.44e-05	5.29e-05	CcSEcCtD
Topiramate—Body temperature increased—Epirubicin—breast cancer	1.44e-05	5.29e-05	CcSEcCtD
Topiramate—Abdominal pain—Epirubicin—breast cancer	1.44e-05	5.29e-05	CcSEcCtD
Topiramate—Hypersensitivity—Methotrexate—breast cancer	1.43e-05	5.26e-05	CcSEcCtD
Topiramate—Asthenia—Methotrexate—breast cancer	1.39e-05	5.13e-05	CcSEcCtD
Topiramate—Feeling abnormal—Doxorubicin—breast cancer	1.39e-05	5.1e-05	CcSEcCtD
Topiramate—Gastrointestinal pain—Doxorubicin—breast cancer	1.38e-05	5.06e-05	CcSEcCtD
Topiramate—Pruritus—Methotrexate—breast cancer	1.37e-05	5.05e-05	CcSEcCtD
Topiramate—Hypersensitivity—Epirubicin—breast cancer	1.34e-05	4.93e-05	CcSEcCtD
Topiramate—Urticaria—Doxorubicin—breast cancer	1.34e-05	4.91e-05	CcSEcCtD
Topiramate—Body temperature increased—Doxorubicin—breast cancer	1.33e-05	4.89e-05	CcSEcCtD
Topiramate—Abdominal pain—Doxorubicin—breast cancer	1.33e-05	4.89e-05	CcSEcCtD
Topiramate—Diarrhoea—Methotrexate—breast cancer	1.33e-05	4.89e-05	CcSEcCtD
Topiramate—Asthenia—Epirubicin—breast cancer	1.3e-05	4.8e-05	CcSEcCtD
Topiramate—Pruritus—Epirubicin—breast cancer	1.29e-05	4.73e-05	CcSEcCtD
Topiramate—Dizziness—Methotrexate—breast cancer	1.28e-05	4.72e-05	CcSEcCtD
Topiramate—Diarrhoea—Epirubicin—breast cancer	1.24e-05	4.57e-05	CcSEcCtD
Topiramate—Hypersensitivity—Doxorubicin—breast cancer	1.24e-05	4.56e-05	CcSEcCtD
Topiramate—Vomiting—Methotrexate—breast cancer	1.23e-05	4.54e-05	CcSEcCtD
Topiramate—Rash—Methotrexate—breast cancer	1.22e-05	4.5e-05	CcSEcCtD
Topiramate—Dermatitis—Methotrexate—breast cancer	1.22e-05	4.5e-05	CcSEcCtD
Topiramate—Headache—Methotrexate—breast cancer	1.22e-05	4.48e-05	CcSEcCtD
Topiramate—Asthenia—Doxorubicin—breast cancer	1.21e-05	4.44e-05	CcSEcCtD
Topiramate—Dizziness—Epirubicin—breast cancer	1.2e-05	4.42e-05	CcSEcCtD
Topiramate—Pruritus—Doxorubicin—breast cancer	1.19e-05	4.38e-05	CcSEcCtD
Topiramate—Vomiting—Epirubicin—breast cancer	1.16e-05	4.25e-05	CcSEcCtD
Topiramate—Nausea—Methotrexate—breast cancer	1.15e-05	4.24e-05	CcSEcCtD
Topiramate—Diarrhoea—Doxorubicin—breast cancer	1.15e-05	4.23e-05	CcSEcCtD
Topiramate—Rash—Epirubicin—breast cancer	1.15e-05	4.22e-05	CcSEcCtD
Topiramate—Dermatitis—Epirubicin—breast cancer	1.14e-05	4.21e-05	CcSEcCtD
Topiramate—Headache—Epirubicin—breast cancer	1.14e-05	4.19e-05	CcSEcCtD
Topiramate—Dizziness—Doxorubicin—breast cancer	1.11e-05	4.09e-05	CcSEcCtD
Topiramate—Nausea—Epirubicin—breast cancer	1.08e-05	3.97e-05	CcSEcCtD
Topiramate—Vomiting—Doxorubicin—breast cancer	1.07e-05	3.93e-05	CcSEcCtD
Topiramate—Rash—Doxorubicin—breast cancer	1.06e-05	3.9e-05	CcSEcCtD
Topiramate—Dermatitis—Doxorubicin—breast cancer	1.06e-05	3.9e-05	CcSEcCtD
Topiramate—Headache—Doxorubicin—breast cancer	1.05e-05	3.88e-05	CcSEcCtD
Topiramate—Nausea—Doxorubicin—breast cancer	9.99e-06	3.67e-05	CcSEcCtD
Topiramate—CA6—Metabolism—PTEN—breast cancer	8.2e-06	7.15e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CG—breast cancer	8.19e-06	7.14e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APRT—breast cancer	8.18e-06	7.13e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—breast cancer	8.13e-06	7.09e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MAPK3—breast cancer	8.12e-06	7.08e-05	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—HRAS—breast cancer	8.07e-06	7.04e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—FASN—breast cancer	8.02e-06	7e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—breast cancer	7.99e-06	6.97e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—breast cancer	7.97e-06	6.95e-05	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—RAF1—breast cancer	7.88e-06	6.88e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—breast cancer	7.87e-06	6.87e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CG—breast cancer	7.85e-06	6.85e-05	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—breast cancer	7.79e-06	6.79e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EGFR—breast cancer	7.72e-06	6.74e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ESRRA—breast cancer	7.69e-06	6.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ANGPTL4—breast cancer	7.69e-06	6.71e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTEN—breast cancer	7.65e-06	6.68e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTEN—breast cancer	7.65e-06	6.68e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CAV1—breast cancer	7.58e-06	6.61e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CD—breast cancer	7.51e-06	6.55e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—breast cancer	7.41e-06	6.47e-05	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—HRAS—breast cancer	7.38e-06	6.44e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—breast cancer	7.35e-06	6.42e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	7.31e-06	6.38e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KRAS—breast cancer	7.29e-06	6.36e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HADHB—breast cancer	7.29e-06	6.36e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPI—breast cancer	7.29e-06	6.36e-05	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—RAF1—breast cancer	7.21e-06	6.29e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CD—breast cancer	7.2e-06	6.28e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALB—breast cancer	7.11e-06	6.2e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTEN—breast cancer	7.09e-06	6.19e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—NOS3—breast cancer	7.09e-06	6.19e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SYNJ2—breast cancer	6.98e-06	6.09e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	6.97e-06	6.08e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—breast cancer	6.97e-06	6.08e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDH7A1—breast cancer	6.95e-06	6.07e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDH1A1—breast cancer	6.95e-06	6.07e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CG—breast cancer	6.9e-06	6.02e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CD—breast cancer	6.9e-06	6.02e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	6.87e-06	6e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—breast cancer	6.81e-06	5.94e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—NOS3—breast cancer	6.8e-06	5.93e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NME1—breast cancer	6.66e-06	5.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ADSL—breast cancer	6.66e-06	5.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—UMPS—breast cancer	6.66e-06	5.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—FHL2—breast cancer	6.66e-06	5.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PHGDH—breast cancer	6.66e-06	5.81e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CB—breast cancer	6.54e-06	5.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—LDHB—breast cancer	6.54e-06	5.7e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HPSE—breast cancer	6.54e-06	5.7e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BRIP1—breast cancer	6.54e-06	5.7e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—NOS3—breast cancer	6.52e-06	5.69e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NDUFS3—breast cancer	6.49e-06	5.66e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—breast cancer	6.48e-06	5.66e-05	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—HRAS—breast cancer	6.45e-06	5.63e-05	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—RAF1—breast cancer	6.3e-06	5.5e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CB—breast cancer	6.27e-06	5.47e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—breast cancer	6.22e-06	5.42e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HRAS—breast cancer	6.2e-06	5.41e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCC1—breast cancer	6.2e-06	5.41e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTA3—breast cancer	6.2e-06	5.41e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMMR—breast cancer	6.2e-06	5.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CHST9—breast cancer	6.1e-06	5.32e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CD—breast cancer	6.07e-06	5.29e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CB—breast cancer	6.02e-06	5.25e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARGC1B—breast cancer	6e-06	5.24e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—breast cancer	5.99e-06	5.23e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—breast cancer	5.96e-06	5.2e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—breast cancer	5.93e-06	5.18e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	5.84e-06	5.1e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	5.84e-06	5.1e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—breast cancer	5.78e-06	5.05e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—breast cancer	5.78e-06	5.05e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—COX11—breast cancer	5.78e-06	5.04e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—NOS3—breast cancer	5.73e-06	5e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTA4—breast cancer	5.67e-06	4.94e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA9—breast cancer	5.67e-06	4.94e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTEN—breast cancer	5.65e-06	4.93e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	5.59e-06	4.88e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	5.54e-06	4.83e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX2—breast cancer	5.52e-06	4.82e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTA2—breast cancer	5.52e-06	4.82e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—breast cancer	5.47e-06	4.78e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX4—breast cancer	5.45e-06	4.76e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SULT1A1—breast cancer	5.45e-06	4.76e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTEN—breast cancer	5.42e-06	4.73e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—breast cancer	5.4e-06	4.71e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—breast cancer	5.4e-06	4.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—IDH1—breast cancer	5.33e-06	4.65e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTA1—breast cancer	5.33e-06	4.65e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CDA—breast cancer	5.29e-06	4.61e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CB—breast cancer	5.29e-06	4.61e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SHMT1—breast cancer	5.29e-06	4.61e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NAT2—breast cancer	5.27e-06	4.6e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—breast cancer	5.24e-06	4.57e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTEN—breast cancer	5.2e-06	4.54e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A5—breast cancer	5.09e-06	4.44e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLCO1B1—breast cancer	5.09e-06	4.44e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—breast cancer	5e-06	4.36e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APRT—breast cancer	4.92e-06	4.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.76e-06	4.16e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—breast cancer	4.73e-06	4.12e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—breast cancer	4.73e-06	4.12e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ESRRA—breast cancer	4.62e-06	4.03e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ANGPTL4—breast cancer	4.62e-06	4.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MED12—breast cancer	4.62e-06	4.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—DPYD—breast cancer	4.62e-06	4.03e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTEN—breast cancer	4.57e-06	3.99e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDOA—breast cancer	4.55e-06	3.97e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NCOA3—breast cancer	4.41e-06	3.85e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—breast cancer	4.41e-06	3.85e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—breast cancer	4.41e-06	3.85e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC2A2—breast cancer	4.38e-06	3.82e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPI—breast cancer	4.38e-06	3.82e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HADHB—breast cancer	4.38e-06	3.82e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.34e-06	3.79e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CPT1A—breast cancer	4.29e-06	3.75e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTR—breast cancer	4.29e-06	3.75e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCG2—breast cancer	4.29e-06	3.75e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HPGDS—breast cancer	4.21e-06	3.67e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HBA1—breast cancer	4.19e-06	3.65e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDH1A1—breast cancer	4.18e-06	3.65e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDH7A1—breast cancer	4.18e-06	3.65e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—breast cancer	4.09e-06	3.57e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTT1—breast cancer	4.08e-06	3.56e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ACHE—breast cancer	4.08e-06	3.56e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ADSL—breast cancer	4.01e-06	3.5e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—UMPS—breast cancer	4.01e-06	3.5e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NME1—breast cancer	4.01e-06	3.5e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PHGDH—breast cancer	4.01e-06	3.5e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FHL2—breast cancer	4.01e-06	3.5e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—breast cancer	3.99e-06	3.48e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BRIP1—breast cancer	3.93e-06	3.43e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HPSE—breast cancer	3.93e-06	3.43e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—LDHB—breast cancer	3.93e-06	3.43e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP17A1—breast cancer	3.87e-06	3.37e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ENO1—breast cancer	3.83e-06	3.34e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS1—breast cancer	3.83e-06	3.34e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—breast cancer	3.82e-06	3.34e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.81e-06	3.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.76e-06	3.28e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP2D6—breast cancer	3.75e-06	3.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTA3—breast cancer	3.73e-06	3.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMMR—breast cancer	3.73e-06	3.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCC1—breast cancer	3.73e-06	3.25e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NCOA2—breast cancer	3.68e-06	3.21e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—breast cancer	3.67e-06	3.2e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.61e-06	3.15e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—FASN—breast cancer	3.57e-06	3.12e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—BCHE—breast cancer	3.56e-06	3.1e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC5A5—breast cancer	3.51e-06	3.07e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTA4—breast cancer	3.41e-06	2.97e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA9—breast cancer	3.41e-06	2.97e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC2A1—breast cancer	3.39e-06	2.96e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NQO1—breast cancer	3.39e-06	2.96e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.32e-06	2.9e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTA2—breast cancer	3.32e-06	2.9e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX2—breast cancer	3.32e-06	2.9e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP3A4—breast cancer	3.31e-06	2.89e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.29e-06	2.87e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SULT1A1—breast cancer	3.28e-06	2.86e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX4—breast cancer	3.28e-06	2.86e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—breast cancer	3.26e-06	2.84e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1B1—breast cancer	3.25e-06	2.84e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—breast cancer	3.22e-06	2.81e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—IDH1—breast cancer	3.2e-06	2.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTA1—breast cancer	3.2e-06	2.8e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.19e-06	2.78e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NAT2—breast cancer	3.17e-06	2.76e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—breast cancer	3.12e-06	2.73e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NCOA1—breast cancer	3.1e-06	2.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP19A1—breast cancer	3.06e-06	2.67e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—STK11—breast cancer	3.06e-06	2.67e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—breast cancer	3e-06	2.61e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.87e-06	2.51e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—COMT—breast cancer	2.84e-06	2.48e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTP1—breast cancer	2.83e-06	2.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMOX1—breast cancer	2.79e-06	2.44e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ITPR1—breast cancer	2.79e-06	2.43e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MED12—breast cancer	2.78e-06	2.42e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—DPYD—breast cancer	2.78e-06	2.42e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDOA—breast cancer	2.73e-06	2.39e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCB1—breast cancer	2.68e-06	2.34e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NCOA3—breast cancer	2.65e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A2—breast cancer	2.64e-06	2.3e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—breast cancer	2.63e-06	2.3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TYMS—breast cancer	2.63e-06	2.3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NCOR1—breast cancer	2.6e-06	2.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.6e-06	2.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—breast cancer	2.6e-06	2.27e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTR—breast cancer	2.58e-06	2.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CPT1A—breast cancer	2.58e-06	2.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCG2—breast cancer	2.58e-06	2.25e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HPGDS—breast cancer	2.53e-06	2.21e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HBA1—breast cancer	2.52e-06	2.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GPX1—breast cancer	2.49e-06	2.17e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1A1—breast cancer	2.47e-06	2.15e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ACHE—breast cancer	2.46e-06	2.14e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTT1—breast cancer	2.46e-06	2.14e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ERCC2—breast cancer	2.45e-06	2.13e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP17A1—breast cancer	2.33e-06	2.03e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS1—breast cancer	2.3e-06	2.01e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ENO1—breast cancer	2.3e-06	2.01e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—breast cancer	2.3e-06	2.01e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2D6—breast cancer	2.26e-06	1.97e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NCOA2—breast cancer	2.22e-06	1.93e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—FASN—breast cancer	2.15e-06	1.87e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—BCHE—breast cancer	2.14e-06	1.87e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CAV1—breast cancer	2.12e-06	1.85e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC5A5—breast cancer	2.11e-06	1.84e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NQO1—breast cancer	2.04e-06	1.78e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC2A1—breast cancer	2.04e-06	1.78e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.03e-06	1.77e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1B1—breast cancer	1.96e-06	1.71e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CG—breast cancer	1.93e-06	1.69e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.92e-06	1.67e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NCOA1—breast cancer	1.87e-06	1.63e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP19A1—breast cancer	1.84e-06	1.61e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—STK11—breast cancer	1.84e-06	1.61e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—COMT—breast cancer	1.71e-06	1.49e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTP1—breast cancer	1.7e-06	1.49e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CD—breast cancer	1.7e-06	1.48e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMOX1—breast cancer	1.68e-06	1.47e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—breast cancer	1.68e-06	1.46e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ITPR1—breast cancer	1.68e-06	1.46e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCB1—breast cancer	1.61e-06	1.41e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NOS3—breast cancer	1.6e-06	1.4e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TYMS—breast cancer	1.58e-06	1.38e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.56e-06	1.37e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—breast cancer	1.56e-06	1.37e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NCOR1—breast cancer	1.56e-06	1.37e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GPX1—breast cancer	1.5e-06	1.31e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1A1—breast cancer	1.48e-06	1.29e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CB—breast cancer	1.48e-06	1.29e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ERCC2—breast cancer	1.47e-06	1.28e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—breast cancer	1.47e-06	1.28e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—breast cancer	1.38e-06	1.21e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTEN—breast cancer	1.28e-06	1.12e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CAV1—breast cancer	1.28e-06	1.11e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CG—breast cancer	1.16e-06	1.01e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CD—breast cancer	1.02e-06	8.91e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—breast cancer	1.01e-06	8.8e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NOS3—breast cancer	9.64e-07	8.41e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—breast cancer	9.02e-07	7.87e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CB—breast cancer	8.9e-07	7.77e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—breast cancer	8.82e-07	7.7e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTEN—breast cancer	7.69e-07	6.71e-06	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—breast cancer	7.37e-07	6.43e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—breast cancer	5.43e-07	4.74e-06	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—breast cancer	4.43e-07	3.87e-06	CbGpPWpGaD
